Toxicological considerations in evaluating indoor air quality and human health: Impact of new carpet emissions

Critical Reviews in Toxicology

Volumn 26, Issue 6, 1996, Pages 633-707

  Dietert, Rodney R ^a   Hedge, Alan ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

carpet emissions; chemical toxicity; human health; indoor air quality; inflammation

Indexed keywords

1,3 BUTADIENE; BENZENE; BENZENE DERIVATIVE; BUTYLCRESOL; CYCLOHEXANOL; CYCLOHEXANONE; CYCLOHEXENE DERIVATIVE; ETHANOL DERIVATIVE; ETHYLBENZENE; FORMALDEHYDE; OZONE; STYRENE; TOLUENE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND; XYLENE;

AIR CONDITIONING; AIR QUALITY; BUILDING; CARCINOGENICITY; DUST; GENOTOXICITY; HUMAN; IMMUNOTOXICITY; INDOOR AIR POLLUTION; INFLAMMATION; MULTIPLE CHEMICAL SENSITIVITY; NEPHROTOXICITY; NEUROTOXICITY; REVIEW; TEMPERATURE;

ANIMALIA;

EID: 0030444286     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408449609037480     Document Type: Review

References (416)

1. Hawkins, N. C., Luedtke, A. E., Mitchell, C. R., LoMenzo, J. A., and Black, M. S., Effects of selected process parameters on emission rates of volatile organic chemicals from carpet, Am. Ind. Hyg. Assoc. J., 53, 275, 1992.
2. Singhvi, R., Burchette, S., and Turpin, R., 4-Phenylcyclohexene from carpet and indoor air quality, in Indoor Air '90, Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 4, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 671.
3. Bayer, C. W., Carpet policy dialogue, Prog. Archit., March, 127, 1991.
4. Bayer, C. W. and Papanicolopoulos, C. D., Exposure assessments to volatile organic compound emissions from textile products, in Indoor Air '90, Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 3, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 725.
5. Black, M. S., Pearson, W. J., and Work, L. M., A methodology for determining VOC emissions from new SBR latex-backed carpet, adhesives, cushions, and installed systems and predicting their impact on indoor air quality, IAQ '91, Healthy Buildings, Atlanta, ASHRAE, 267, 1991.
6. Gustafsson, H., Building materials identified as major emission sources, IAQ '91, Healthy Buildings, Atlanta, ASHRAE, 259, 1991.
7. Anderson, R. C., Toxic emissions from carpet, in Building Design, Technology, and Occupant Well-Being in Temperate Climates, Sterling, E., Bieva, C., and Collett, C., Eds., ASHRAE, Atlanta, 1993, 259.
8. Anderson, R. C., Toxic emissions from carpet, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 651.
9. Dyer, R. S., Report: Open scientific meeting on carpet emissions: animal testing, Health Effects Research Laboratory, U. S. EPA, Research Triangle Park, NC, February, 1994.
10. Indoor Air Quality: Organic Pollutants, EURO Reports and Studies 111, World Health Organization, 1989.
11. Mølhave, L. and Nielsen, G. D., Interpretation and limitations of the concept "Total Volatile Organic Compounds" (TVOC) as an indicator of human responses to exposures of volatile organic compounds (VOC) in indoor air, Indoor Air, 2, 65, 1992.
12. Hodgson, A. T., Wooley, J. D., and Daisey, J. M., Volatile Organic Chemical Emissions from Carpets, Final Report LBL, 31916, Interagency Agreement CPSC, IAGF, 90, 1256, U.S. Consumer Product Safety Commission, Lawrence Berkeley Laboratory, Berkeley, CA, April, 1992.
13. Hodgson, A. T., Wooley, J. D., and Daisey, J. M., Emissions of volatile organic compounds from new carpets measured in large, scale environmental chamber, J. Air Waste Manage. Assoc., 43, 316, 1993.
14. Sollinger, S., Levsen, K., and Wünsch, G., Indoor air pollution by organic emissions from textile floor coverings. Climate chamber studies under dynamic conditions, Atmos. Environ., 27B, 183, 1993.
15. Black, M. S., Environmental chamber technology for the study of volatile organic compound emissions from manufactured products, in Indoor Air '90: Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 3, Toronto, Canada, 1990, 713.
16. Black, M. S., Work, L. M., Worthan, A. G., and Pearson, W. J., Measuring the TVOC contributions of carpet using environmental chambers, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 2, Helsinki, Finland, 1993, 401.
17. Davidson, J. L., Black, M. S., Pearson, W. J., Work, L. M., and Miller, D. P., Carpet installation during building renovation and its impact on indoor VOC concentration, in IAQ '91, Healthy Buildings, Atlanta, ASHRAE, 1991, 299.
18. Singhvi, R. and Haseman, D., Indoor air quality study of renovated office space, in Indoor Air '93: Proc. 6th Int. Conf.Indoor Air Quality and Climate, Vol. 2, Helsinki, Finland, 1993, 99.
19. Schröder, E., Textile floor coverings and indoor air quality, in Indoor Air '90, Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 3, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 719.
20. Wolkoff, P., Nielsen, G. D., Hansen, L. F., Albrechtsen, O., Johnsen, C. R., Heinig, J. H., and Frank, C., Controlled human reactions to building materials in climatic chambers. Part II: VOC measurements, mice bioassay, and decipol evaluation, in Indoor Air '90, Proc. 5th Int. Conf. Indoor Air Quality and Climate, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 331.
21. Tucker, W. G., Building with low emitting materials and products: where do we stand, in Indoor Air '90, Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 3, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 251.
22. U.S. EPA, Test method for determining total volatile organic compound emissions factors from carpet under defined test conditions using small environmental chambers, Carpet Policy Dialogue, Compendium Report, September, 1991.
23. ASTM, Standard guide for small-scale environmental chamber determinations of organic emissions from indoor materials/products, ASTM D5116-90, Philadelphia, PA, 1990.
24. Winberry, T., Forehand, L., Murphy, N., Phinne, B., and Evans, A., Compendium of methods for the detection of air pollutants in indoor air, Environmental Protection Agency, EPA Report 600/4-90/010, Washington, D.C.
25. Bertoni, G., Bruner, F., Liberti A., and Perrino, C., Some critical parameters in collection, recovery, and gas chromatographic analysis of organic pollutants in ambient air using light adsorbents, J. Chromatogr., 203, 263, 1981.
26. Bruner, F., Bertoni, G., and Crescentini, G., Critical evaluation of sampling and gas chromatographic analysis of hydrocarbons and other organic air pollutants, J. Chromatogr., 167, 399, 1978.
27. Mangani, F., Mastrogiacomo, A., and Marras, O., Evaluation of working conditions of light adsorbents and their use as sampling materials for the GC analysis of organic air pollutants in work areas, Chromatographia, 15, 712, 1982.
28. Wechsler, C. J., Hodgson, A. T., and Wooley, J. D., Indoor chemistry: ozone, volatile organic compounds, and carpets, Environ. Sci. Technol., 26, 2371, 1992.
29. ACGIH, Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices, American Conference of Governmental Industrial Hygienists, Cincinnati, OH, 1994.
30. Pickrell, J. A., Mokler, B. V., Griffis, L. C., Hobbs, C. H., and Bathija, A., Formaldehyde release rate coefficients from selected consumer products, Environ. Sci. Technol., 17, 753, 1983.
31. Godish, T. and Kanyer, B., Formaldehyde source interaction studies, For. Prod. J., 35, 13, 1985.
32. Dingle, P., Olden, P., Shuwee, H., and Murray, F., A study of formaldehyde in a new office building, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 2, Helsinki, Finland, 1993, 51.
33. Tincher, W. C., Shepherd, A. B., and Statham, D. L., Analyzing carpet samples for formaldehyde content, Text. Chem. Color., 21, 27, 1989.
34. Mader J. W. and Mitchell, C. R., Analyzing carpet samples for formaldehyde content, Text. Chem. Color., 21, 30, 1989.
35. Safety Assessment of Components of, and Emissions from, Carpets, ENVIRON Corp., Arlington, VA, June, 1994.
36. Siefert, B., Ullrich, D., and Nagel, R., Volatile organic compounds from carpeting, Man and His Ecosystem: Proc. 8th World Clean Air Congress, Vol. 1, Brasser, L. J. and Mulder, W. C., Eds., Institute for Water, Soil, and Air Hygiene, The Hague, Netherlands, 1989, 253.
37. Pliel, J. D. and Whiton, R. S., Determination of organic emissions from new carpeting, Appl. Occup. Environ. Hyg., 5, 693, 1990.
38. Jarabek, A. M., Inhalation RfC methodology: dosematric adjustment and dose-response estimation of non-cancer toxicity in the upper respiratory tract, Inhal. Toxicol., 6 (Suppl.), 301, 1994.
39. Terra Inc., A safety assessment of carpet emissions, Tallahassee, FL, May 7, 1990. (Available from the CRI, PO Box 2048, Dalton, GA 30722).
40. i): an application of interspecies dosimetry modeling for risk assessment of insoluble particles, Health Phys., 57 (1), 177-183, 1989.
41. Hetes, R. G., Womack, D. S., Pierson, T. K., and Naugle, D. F., Final report, Prepared for the U.S. Environmental Protection Agency, National Center of Environmental Assessment, Research Triangle Park, NC, February, 1992.
42. Barnes, D. G., Daston, G. P., Evans, J. S., Jarabek, A. M., Kavlock, R. J., Kimmel, C. A., Park, C., and Spitzer, H. L., Benchmark Dose Workshop: Criteria for use of a benchmark dose to estimate a reference dose, Regul. Toxicol. Pharmacol. J., 21, 2, 296, 1995.
43. Alarie, Y. and Stock, M. F., Toxicological investigations of carpet Z volatile emissions and development of a standard carpet emission generation system, Research report, Department Environmental and Occupational Health, University of Pittsburgh, 1993.
44. Air Quality Sciences, Indoor air quality evaluation of carpet at four different temperature, AQS report, No. 01376-01, February 26, 1993.
45. Air Quality Sciences, A study of carpet emissions and sensory irritation in mice (Phase): Carpet Product at #3, AQS report, No. 01402-1A, March 4, 1993.
46. Air Quality Sciences, A study of carpet emissions and sensory irritation in mice (Phase 1), Carpet Product at #3 at 38%C, AQS report, No. 01402-4A, March 19, 1993.
47. Air Quality Sciences, A study of carpet emissions and sensory irritation in mice (Phase 1), Carpet Product at #3 at 60%C, AQS report, No. 01402-6A, March 26, 1993.
48. Air Quality Sciences, A study of carpet emissions and sensory irritation in mice (Phase 1), Carpet Product at #3 at 70%C, AQS report. No. 01402-5A, March 22, 1993.
49. Ponessa, J. T., Carpet, paint, and indoor air quality, Housing Soc., 19, 117, 1992.
50. Saarela, K. and Mattinen, M., Variation in volatile organic compounds in a new office building as a function of time, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 2, Helsinki, Finland, 1993, 75.
51. Rothweiler, H., Wäger, P. A., and Schlatter, C., Increased VOC concentrations in new and recently renovated buildings and their impact on the inhabitants, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 2, Helsinki, Finland, 1993, 153.
52. Rothweiler, H., Wäger, P. A., and Schlatter, C., Long term emissions from two glued carpets with different backings measured in indoor air. Environ. Technol., 13, 891, 1992.
53. Tossavainen, A., Styrene use and occupational exposure in the plastics industry, Scand. J. Work Environ. Health, 4, 7, 1978.
54. Brown, S. K., Sim, M. R., Abramson, M. J., and Gray, C. N., Concentrations of volatile organic compounds in indoor air - a review. Indoor Air, 4, 123, 1994.
55. Alarie, Y., Dose-response analysis in animal studies: prediction of human responses, Environ. Health Perspect., 42, 9, 1981.
56. Härkönen, H., Styrene, its experimental and clinical toxicology, Scand. J. Work Environ. Health, 4, 104, 1978.
57. Lorimer, W. J., Styrene and butadiene, in Environmental and Occupational Medicine, 1983, chap. 56.
58. Groth-Marnat, G., Neuropsychological effects of styrene exposure: a review of current literature. Percept. Motor Skills, 77, 1139, 1993.
59. Pahwa, R. and Kalra, J., A critical review of the neurotoxicity of styrene in humans, Vet Hum. Tax., 35, 516, 1993.
60. Engström, K., Bjurström, R., Åstrand, I., and Övrum, P., Uptake, distribution and elimination of styrene in man, Scand. J. Work Environ. Health, 4, 315, 1978.
61. Engström, K., Hårkönen, H., Kalliokoski, P., and Rantanen, J., Urinary mandelic acid concentration after occupational exposure to styrene and its use as a biological exposure test, Scand. J. Work Environ. Health, 2, 21, 1976.
62. Pezzagno, G., Ghittori, S., Imbriani, M., and Capodaglio, E., Urinary elimination of styrene in experimental and occupational exposure, Scand. J. Work Environ. Health, 11, 371, 1985.
63. Ramsey, J. C. and Andersen, M. E., A physiologically based description of the inhalation pharmokinetics of styrene in rats and humans, Toxicol. Appl. Pharmacol., 73, 159, 1984.
64. Askergren, A., Allgén, L., Karlsson, C., Lundberg, I., and Nyberg, E., Studies in kidney function in subjects exposed to organic solvents. Acta Med. Scand., 209, 479, 1981.
65. Arfini, G., Mutti, A., Vescovi, P., Ferroni, C., Ferrari, M., Giaroli, C., Passeri, M., and Franchini, I., Impaired domaminergic modulation of pituitary secretion in workers occupationally exposed to styrene: further evidence from PRL response to TRH stimulation, J. Occup. Med., 29, 826, 1987.
66. Hodgson, J. T. and Jones, R. D., Mortality of styrene production, polymerization, and processing workers at a site in Northwest England, Scand. J. Work Environ. Health, 11, 347, 1985.
67. Fleig, I. and Thiess, A. M., Mutagenicity study of workers employed in the styrene and polystyrene processing and manufacturing industry, Scand. J. Work Environ. Health, 4, 254, 1978.
68. Brenner, D. D., Jeffrey, A. M., Latriano, L., Wazneh, L., Warburton, D., Toor, M., Pero, R. W., Andrews, L. R., Walles, S., and Perera, F. P., Biomarkers in styrene-exposed boatbuilders, Mutat. Res., 261, 225, 1991.
69. Pero, R. W., Bryngelsson, T., Högstedt, B., and Åkesson, B., Occupational and in vitro exposure to styrene assessed by unscheduled DNA synthesis in resting human lymphocytes, Carcinogenesis, 3, 681, 1982.
70. Watanabe, T., Endo, A., Kumai, M., and Ikeda, M., Chromosome aberrations and sister chromatid exchanges in styrene-exposed workers with reference to their smoking habits, Environ. Mutagen., 5, 299, 1983.
71. Meretoja, T., Järventaus, H., Sorsa, M., and Vainio, H., Chromosome aberrations in lymphocytes of workers exposed to styrene, Scand. J. Work Environ. Health, 4, 259, 1978.
72. Linnainmaa, K., Meretoja, T., Sorsa, M., and Vainio, H., Cytogenetic effects of styrene and styrene oxide on human lymphocytes and Allium cepa, Scand. J. Work Environ. Health, 4, 156, 1978.
73. Pagano, G., Esposito, A., Giordano, G. G., and Hagström, B. E., Embryotoxic and teratogenic effects of styrene derivatives on sea urchin development, Scand. J. Work Environ. Health, 4, 136, 1978.
74. Loprieno, N., Presciuttini, S., Sbrana, I., Stretti, G., Zaccaro, L., Abbondandolo, A., Bonatti, S., Fiorio, R., and Mazzaccaro, A., Mutagenicity of industrial compounds. VII. Styrene and styrene oxide: II. Point mutations, chromosome aberrations and DNA repair induction analyses, Scand. J. Work Environ. Health, 4, 169, 1978.
75. Pohlová, H. and Srám, R. J., Cytogenetic analysis of peripheral blood lymphocytes of workers occupationally exposed to styrene, J. Hyg. Epidemiol. Microbiol. Immunol., 28, 155, 1985.
76. Geuskens, R. B., Van Der Klaauw, M. M., Van Der Tuin, J., and Van Hemmen, J. J., Exposure to styrene and health complaints in the Dutch glass-reinforced plastics industry, Ann. Occup. Hyg., 36, 47, 1992.
77. Jégaden, D., Amann, D., Simon, J. F., Habault, M., Legoux, B., and Galopin, P., Study of the neurobehavioural toxicity of styrene at low levels of exposure, Int. Arch. Occup. Environ. Health, 64, 527, 1993.
78. Rosengren, L. E. and Haglid, H. G., Long-term neurotoxicity of styrene: a quantitative study of glial fibrillary acidic protein (GFA) and S-100, Br. J. Ind. Med., 46, 316, 1989.
79. Zaidi, N. F., Agrawal, A. K., Srivastava, S. P., and Seth, P. K., Effect of styrene oxide on dopamine receptors in rats, Bull. Contam. Toxicol., 35, 602, 1985.
80. Trenga, C. A., Kunkel, D. D., Eaton, D. L., and Costa, L. G., Effect of styrene oxide on rat brain glutathione, Neurotoxicology, 12, 165, 1991.
81. Singh, A. P. and Srivastava, S. P., Inhibitory characteristics of styrene oxide on Na+,K+ activated adenosine triphosphatase, JEPTO, 6, 29, 1986.
82. Letz, R., Mahoney, F. C., Hershman, D. L., Woskie, S., and Smith, T. J., Neurobehavioral effects of acute styrene exposure in fiberglass boatbuilders, Neurotoxicol. Teratol., 12, 665, 1990.
83. Rosén, L, Haeger, Aronsen, B., Rehnström, S., and Welinder, H., Neurophysiological observations after chronic styrene exposure, Scand. J. Work Environ. Health, 4, 184, 1978.
84. Seppäläinen, A., Neurotoxicity of styrene in occupational and experimental exposure, Scand. J. Work Environ. Health, 4, 181, 1978.
85. Murata, K., Araki, S., and Yokoyama, K., Assessment of the peripheral, central, and autonomic nervous system function in styrene workers, Am. J. Ind. Med., 20, 775, 1991.
86. Triebig, G., Lehrl, S., Weltle, D., Schaller, K. H., and Valentin, H., Clinical and neurobehavioural study of the acute and chronic neurotoxicity of styrene, Br. J. Ind. Med., 46, 799, 1989.
87. Triebig, G., Schaller, K. H., and Valentin, H., Investigations on neurotoxicity of chemical substances at the workplace, Int. Arch. Occup. Environ. Health, 56, 239, 1985.
88. Teramoto, K., Wakitani, F., Horiguchi, S. J., Yamamoto, T., Mitsutake, H., and Nakaseko, H., Comparison of the neurotoxicity of several chemicals estimated by the peripheral nerve conduction velocity in rats, Environ. Res., 62, 148, 1993.
89. Beiswanger, C. M., Mandella, R. D., Graessle, T. R., Reuhl, K. R., and Lowndes, H. E., Synergistic neurotoxic effects of styrene oxide and acrylamide: glutathione-independent necrosis of cerebellar granule cells, Toxicol. Appl. Pharmacol., 118, 233, 1993.
90. Ikeda, M. and Hirayama, T., Possible metabolic interaction of styrene with organic solvents, Scand. J. Work Environ. Health, 4(2), 41, 1978.
91. Morgan, D. L., Mahler, J. F., O'Connor, R. W., Price, H. C., and Adkins, B., Styrene inhalation toxicity studies in mice, Fundam. Appl. Toxicol., 20, 325, 1993.
92. Härkönen, H., Lehtniemi, A., and Aitio, A., Styrene exposure and the liver, Scand. J. Work Environ. Health, 10, 59, 1984.
93. Parkki, M. G., The role of glutathione in the toxicity of styrene, Scand. J. Work Environ. Health, 4, 53, 1978.
94. Dogra, R. K. S., Chandra, K., Chandra, S., Gupta, S., Khanna, S., Srivastava, S. N., Shukla, L. J., Katiyar, J. C., and Shanker, R., Host resistance assays as predictive models in styrene immunomodulation, Int. Soc. Immunol. Pharmacol., 14, 1003, 1992.
95. Dogra, R. K. S., Khanna, S., Srivastava, S. N., Shukla, L. J., Chandra, K., Saxena, G., and Shanker, R., Immunomodulation due to coexposure to styrene and dioctly phthalate in mice, Immunol. Pharmacol. Immunotoxicol., 15, 491, 1993.
96. Ponomarkov, V. and Tomatis, L., Effects of long-term oral administration of styrene to mice and rats, Scand. J. Work Environ. Health, 4, 127, 1978.
97. Santos-Burgoa, C., Matanoski, G. M., Zeger, S., and Schwartz, L., Lymphohematopoietic cancer in styrene-butadiene polymerization workers, Am. J. Epidemiol., 136, 843, 1992.
98. Heseltine, E., Peltonen, K., Sorsa, M., and Vainio H., Assessment of the health hazards of 1,3-butadiene and styrene, J. Occup. Med., 35, 1089, 1993.
99. Nitschke, K. D., Mizell, M. J., Beekman, M. J., and Lomax, L. G., Dermal sensitization potential and inhalation toxicological evaluation of 4-phenylcyclohexene, Am. Ind. Hyg. Assoc. J., 52, 192, 1991.
100. Mizell, M. J., 4-Phenylcyclohexene: dermal sensitization potential in the Hartley albino guinea pig. Report DD-000969-002, The Dow Chemical Company. Midland, Michigan, 1989.
101. Beekman, M. J., Young, J. T., and Rautio, A. W., 4-Phenycyclohexene: two-week inhalation and neurotoxicity study in Swiss-Webster mice, Dow Chemical Company Study, ID: DD-000969-008, 1993.
102. Hooser, S. B., Parola, L. R., VanErt, M. D., and Sipes, I. G., Differential ovotoxicity of 4-vinylcyclohexene and its analog, 4-phenylcyclohexene, Toxicol. Appl. Pharmacol., 119, 302, 1993.
103. Stadler, J. C., Subchronic toxicity study by the inhalation route in rats and mice with 4-vinylcyclohexene. Du Pont HLR, 1, 10, 1994.
104. Smith, B. J., Sipes, I. G., Stevens, J. C., and Halpert, J. R., The biochemical bais for the species difference in hepatic microsomal 4-vinylcyclohexene expoxidation between female mice and rats, Carcinogenesis, 11, 1951, 1990.
105. Smith, B. J. and Sipes, I. G., Short communication, Epoxidation of 4-vinylcyclohexene by human hepatic microsomes, Toxicol. Appl. Pharmacol., 109, 367, 1991.
106. Collins, J. J. and Manus, A. G., Toxicological evaluation of 4-vinylcyclohexene. I. Prechronic (14-day) and subchronic (13-week) gavage studies in Fischer 344 rats and B6C3F1, mice, J. Toxicol. Environ. Health, 21, 493, 1987.
107. Collins, J. J., Montali, R. J., and Manus, A. G., Toxicological evaluation of 4-vinylcyclohexene. II. Induction of ovarian tumors in female B6C3F1 mice by chronic oral administration of 4-vinylcyclohexene, J. Toxicol. Environ. Health, 21, 507, 1987.
108. Shah, J. J. and Singh, H. B., Distribution of volatile organic chemicals in outdoor and indoor air (a national VOCs data base), Environ. Sci. Technol., 22, 1381, 1988.
109. Kristiansen U. and Nielsen, G. D., Activation of the sensory irritant receptor by C7-C11 n-alkanes. Arch. Toxicol., 61, 419, 1988.
110. Nielsen, G. D. and Alarie, Y., Sensory irritation, pulmonary irritation, and respiratory stimulation by airborne benzene and alkyl benzenes: prediction of safe industrial exposure levels and correlation with their thermodynamic properties, Toxicol. Appl. Pharmacol., 65, 459, 1982.
111. Cometto-Muniz, J. E. and Cain, W. S., Sensory reactions of nasal pungency and odor to volatile organic compounds: the alkylbenzenes, Am. Ind. Hyg. Assoc. J., 55, 811, 1994.
112. Nilsen O. G., Haugen, O. A., Zahlsen, K., Halgunset, J., Helseth, A., Aarset, H., and Eide, I., Toxicity of n-C9 to n-C13 alkanes in the rat on short term inhalation, Pharmacol. Toxicol., 62, 259, 1988.
113. Rabovsky, J. and Judy, D. J., The in vitro effects of alkanes, alcohols, and ketones on rat lung cytochrome P450-dependent alkoxyphenoxazone dealkylase activities, Arch. Toxicol., 63, 13, 1989.
114. Min, D. B. S., Ina, K., Peterson, R. J., and Chang, S. S., Preliminary identification of volatile flavor compounds in the neutral traction of roast beef, J. Food Scl., 44, 639, 1979.
115. Fishbein, L., An overview of environmental and toxicological aspects of aromatic hydrocarbons. IV. Ethylbenzene, Sci. Total Environ., 44, 269, 1985.
116. Von Burg, R., Ethybenzene, J. Appl. Toxicol., 12, 69, 1992.
117. Wolf, M. A., Rowe, W. K., McCollister, D. D., Hollingsworth, R. L., and Oyen, F., Toxicological studies of certain alkylated benezenes and benzene, Arch. Ind. Health, 14, 387, 1956.
118. Yant, W. P., Schrenk, H. H., Waite, C. P., and Patty, R. A., Acute response of guinea pigs to vapors of some new organic compounds: ethylbenzene, U.S. Treas. Public Health Rep., 45, 124, 1930.
119. Engström, K. and Bjurström, R., Exposure to xylene and ethylbenzene. II. Concentration in subcutaneous adipose tissue, Scand. J. Work Environ. Health, 4, 195, 1978.
120. Gamberale, F., Ann wall, G., and Hultengren, M., Exposure to xylene and ethylbenzene. III. Effects on central nervous functions, Scand. J. Work Environ. Health, 4, 204, 1978.
121. Kane, L. E., Dombroske, R., and Alarie, Y., Evaluation of sensory irritation from some common industrial solvents, Am. Ind. Hyg. Assoc. J., 41, 451, 1980.
122. Shyr, L. J., Suborin, P. J., Medinski, M. A., Birnbaum, L. S., and Henderson, R. F., Physiologically based modeling of 2-butoxy ethanol disposition in rats following different routes of exposure, Environ. Res., 63, 202, 1993.
123. Giraudi, G. and Baggiani, C., Solvent effect on testosterone, antitestosterone interaction, Biochim. Biophys. Acta, 1157, 211, 1993.
124. Exon, J. H., Mather, G. G., Bussiere, J. L., Olson, D. P., and Talcott, P. A., Effects of subchronic exposure of rats to 2- methoxyethanol or 2-butoxy ethanol: thymic atrophy and immunotoxicity, Fundam. Appl. Toxicol., 16, 830, 1991.
125. Smialowicz, R. J., Williams, W. C., Riddle, M. M., Andrews, D. L., Luebke, R. W., and Copeland, C. B., Comparative immunosuppression of various glycol ethers orally administered to Fischer 344 rats 1,2, Fundam. Appl. Toxicol., 18, 621, 1992.
126. Ghanayem, B. J., Investigation of the mechanisms of 2-butoxyethanol induced hemolytic anemia in rats and assessment of human risk in vitro, Biochem. Pharmacol., 38, 1679, 1989.
127. Ghanayem, B. I., Burka, L. T., and Matthews, H. B., Metabolism and disposition of ethylene glycol monobutylether (2-butoxyethanol) in rats, Drug Metab. Dispos., 15, 478, 1987.
128. Ghanayem, B. L, Blair, P. C., Thompson, M. B., Maronpot, R. R., and Matthews, H. B., Effect of age on the toxicity and metabolism of ethylene glycol monobutyl ether (2-butoxyethanol) in rats, Toxicol. Appl. Pharmacol., 91, 222, 1987.
129. Ghanayem, B. J., Burka, L. T., and Matthews, H. B., Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases 1, J. Pharmacol. Exp. Ther., 242, 222, 1987.
130. Ghanayem, B. J., Sanchez, I. M., and Matthews, H. B., Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms, Toxicol. Appl. Pharmacol., 112, 198, 1992.
131. Johanson, G. and Johnson, S., Gas chromatographic determination of butoxyacetic acid in human blood after exposure to 2-butoxyethanol, Arch. Toxicol., 65, 433, 1991.
132. Persoon-Rothert, M., Egas-Kenniphaas, J. M., VanDer Valk-Kokshoorn, E. J. M., Buys, J. P., and Van Der Laarse, A., Oxidative stress-induced perturbations of calcium nomeostasis and cell death in cultured myocytes: role of extracellular calcium, Mol. Cell. Biochem., 136, 1, 1994.
133. Schenkman, J. B., Voznesensky, A. I., and Jansson, I., Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b-5 in the process, Arch. Biochem. Biophys., 314, 234, 1994.
134. Brennan, R. J., Swoboda, B. E. P., and Schiestl, R. H., Oxidative mutagens induce intrachromosomal recombinations in yeast, Mutat. Res., 308, 159, 1994.
135. Donald, J. M., Hooper, K., and Hopenhayn, R., Reproductive and developmental toxicity of toluene: a review, Environ. Health Perspect., 94, 237, 1991.
136. Freundt, K. J., Römer, K. G., and Federsel, R. J., Decrease of inhaled toluene, ethyl benzene, m-xylene, or mesitylene in rat blood after combined exposure to ethyl acetate, Bull. Environ. Contam. Toxicol., 42, 495, 1989.
137. Shen, C-L., Ting, W.-H., and Chang, T.-K., Effects of toluene on the morphology of neuropeptide secretory neurons of the rat hypothalamus, Proc. Natl. Sci. Counc. ROC, 16, 162, 1992.
138. Matsushita, T., Arimatsu, T., Ueda, A., et al., Haematological and neuromuscular response of workers exposed to low concentration of toluene vapor, Ind. Health, 13, 115, 1975.
139. Grasso, P., Neurotoxic and neurobehavioral effects of organic solvents on the nervous system, Occup. Med. State Art Rev., 3, 525, 1988.
140. Abbate, C., Giorgianni, C., Munao, F., and Brecciaroli, R., Neurotoxicity induced by exposure to toluene, Int. Arch. Occup. Environ. Health, 64, 389, 1993.
141. De Grandarias, J. M., Echevarria, E., Irazusta, J., Casis, E., and Casis, L., Lys- and leu-aminopeptidase activity after acute toluene exposure in the rat brain, Toxicol. Ind. Health, 9, 511, 1993.
142. Dyer, R. S., Bercegeay, M. S., and Mayo, L. M., Acute exposures to p-xylene and toluene alter visual information processing, Neurotoxicol. Teratol., 10, 147, 1988.
143. Gamberale, F. and Hultengren, M., Toluene exposure. II. Psychophysiological functions, Work Environ. Health, 9, 131, 1972.
144. Mattia, C. J., LeBel, C. P., and Bondy, S. C., Effects of toluene and its metabolites on cerebral reactive oxygen species generation, Biochem. Pharmacol., 42, 879, 1991.
145. Hsieh, G. C., Sharma, R. P, Parker, R. D. R., and Coulombe, R. A., Evaluation of toluene exposure via drinking water on levels of regional brain biogenic amines and their metabolites in CD 1 mice, Ecotoxicol. Environ. Saf., 20, 175, 1990.
146. Hsieh, G. C., Sharma, R. P., and Parker, R. D. R., Hypothalamic, pituitary, adrenocortical axis activity and immune function after oral exposure to benzene and toluene, Immunol. Pharmacol., 21, 23, 1991.
147. Hood, R. D. and Ottley, M. S., Developmental effects associated with exposure to xylene: a review. Drug Chem. Toxicol., 8, 281, 1985.
148. Engström, K., Husman, K., Pfäffli, P., and Riihimaki, V., Evaluation of occupational exposure to xylene by blood, exhaled ak and urine analysis, Scand. J. Work Environ. Health, 4, 114, 1978.
149. Kawai, T., Mizunuma, K., Yasugi, T., Horiguchi, S., Uchida, Y., Iwami, O., Iguchi, H., and Ikeda, M., Urinary methylhippuric acid isomer levels after occupational exposure to a xylene mixture. Int. Arch. Occup. Environ. Health, 63, 69, 1991.
150. Laine, A., Savolainen, K., Riihimaki, V., Matikainen, E., Salmi, T., and Juntunen J., Acute effects of m-xylene inhalation on body sway, reaction times, and sleep in man, Int. Arch. Occup. Environ. Health, 65, 179, 1993.
151. Rosen, M. B., Crofton, K. M., and Chernoff, N., Postnatal evaluation of prenatal exposure to p-xylene in the rat, Toxicol. Lett., 34, 223, 1986.
152. Bushnell, P. J. and Peele, D. B., Conditioned flavor aversion induced by inhaled p-xylene in rats, Neurotoxicol. Teratol., 10, 273, 1988.
153. Padilla, S., Lyerly, D. L., and Pope, C. N., Subacute ethanol consumption reverses p-xylene-induced decreases in axonal transport, Toxicology, 75, 159, 1992.
154. Silverman, D. M. and Schatz, R. A., Pulmonary microsomal alterations following short-term low level inhalation of p-xylene in rats, Toxicology, 65, 271, 1991.
155. Stickney, J. A., Roberts, A. E., Silverman, D. M., and Schatz, R. A., The effect of m-xylene on rat lung benzo[a]pyrene metabolism and microsomal membrane lipids: comparison with p-xylene. Toxicology, 58, 155, 1989.
156. Day, B. J., DeNicola, D. B., Marcus, C. B., and Carlson, G. P., Effect of p-xylene inhalation on the bioactivation of bromobenzene in rat lung and liver, Fundam. Appl. Toxicol., 19, 50, 1992.
157. Roberts, A. E., LeBeI, C. P., Stickney, J. A., Silverman, D., Brown, D. R., and Schatz, R. A., Changes in rat lung microsomal lipids after p-xylene: relationship to inhibition of benzo[a]pyrene metabolism, J. Toxicol. Environ. Health, 25, 479, 1988.
158. Nemery, B. and Aldridge, W. N., Studies on the metabolism of the pneumotoxin O,S,S-trimethyl phosphorodithioate-II lung and liver slices, Biochem. Pharmacol., 37, 3717, 1988.
159. Selgrade, M. J. K., Daniels, M. J., Jaskot, R. H., Robinson, B. L., and Allis, J. W., Enhanced mortality and liver damage in virus-infected mice exposed to p-xylene, J. Toxicol. Environ. Health, 40, 129, 1993.
160. Bos, P. M. J., Zwart, A., Reuzel, P. G. J., and Bragt, P. C., Evaluation of the sensory irritation test for the assessment of occupational health risk, Crit. Rev. Toxicol., 21, 423, 1992.
161. Parodi, S., Abelmoschi, M. L., Balbi, C., De-Angeli, M. T., Pala, M., Russo, P., Taningher, M., and Santi, L., DNA damage in mouse and rat liver by caprolactam and benzoin evaluated with three different methods, Mutat. Res., 224, 379, 1989.
162. Gad, S. C., Robinson, K., Serota, D. G., and Colpean, B. R., Developmental toxicity studies of caprolactam in the rat and rabbit, J. Appl. Toxicol., 7, 317, 1987.
163. Mraz, J., Galova, E., Nohova, H., and Vitkova, D., Markers for exposure to cyclohexanone, cyclohexane and cyclohexanol, Clin. Chem., 40, 1466, 1994.
164. Groth, G., Schreeb, K., Herdt, V., and Freundt, K. J., Toxicity studies in fertilized zebrafish eggs treated with n-methylamine, n,n-dimethylamine, 2-aminoethanol, isopropylamine, aniline, n-methylaniline, n,n-dimethylaniline, quinone, chloroacetaldehyde, or cyclohexanol, Bull. Environ. Contam. Toxicol., 50, 878, 1993.
165. De Ceaurriz, J. C., Micillino, J. C., Bonnet, P., and Guenier, J. P., Sensory irritation caused by various industrial airborne chemicals, Toxicol. Lett., 9, 137, 1981.
166. Mraz, J., Galova, E., Nohova, H., and Vitkova, D., Metabolism and elimination of cyclohexanone in humans. Int. Arch. Occup. Environ. Health, 66, 203, 1994.
167. Lijinsky, W. and Kovatch, R. M., Chronic toxicity study of cyclohexanone in rats and mice, J. Natl. Cancer Inst., 77, 941, 1986.
168. Olsen, P., Meyer, O., Bille, N., and Wurtzen, G., Carcinogenicity study on butylated hydroxytoluene (BHT) in Wistar rats exposed in utero, Food Chem. Toxicol., 24, 1, 1986.
169. Inai, K., Kobuke, T., Nambu, S., Takemoto, T., Kou, E., Nishina, H., Fujihara, M., Yonehara, S., Suehiro, S., Tsuya, T., Horiuchi, K., and Tokuoka, S., Hepatocellular tumorigenicity of butylated hydroxytoluene administered orally to B6C3F1 mice, Jpn. J. Cancer Res., 70, 343, 1988.
170. Williams, G. M., Wang, C. X., and Iatropoulos, M. J., Toxicity studies of butylated hydroxyanisole and butylated hydroxytoluene. II. Chronic feeding studies, Fundam. Chem. Toxicol., 28, 799, 1990.
171. Shertzer, H. G., Bannenberg, G. L., Rudgren, M., and Moldeus, P., Relationship of membrane fluidity, chemoprotection, and the intrinsic toxicity of butylated hydroxytoluene, Biochem Pharmacol., 42, 1587, 1991.
172. Frolkis, V. V., Gorban, E. N., and Koltover, V. K., Effects of antioxidant butylated hydroxytoluene (BHT) on hormonal regulation and ESR signals in adult and old rats, Age, 13, 5, 1990.
173. Tanaka, T., Oishi, S., and Takahashi, O., Three generation toxicity study of butylated hydroxytoluene administered to mice, Toxicol. Lett., 66, 295, 1993.
174. Takahashi, O., Hemorrhages due to defective blood coagulation do not occur in mice and guinea-pigs fed butylated hydrozytoluene, but nephrotoxicity is found in mice, Fundam. Chem. Toxicol., 30, 89, 1992.
175. Zenz, C., Benzene - attempts to establish a lower exposure standard in the United States, Scand. J. Work Environ. Health, 4, 103, 1978.
176. Snyder, R. and Kalf, G. F., A perspective on benzene leukemogenesis, Crit. Rev. Toxicol., 24, 177, 1994.
177. Paustenbach, D. J., Bass, R. D., and Price, P., Benzene toxicity and risk assessment, 1972-1992: implications for future regulations, Environ. Health Perspect., 101(86), 177, 1993.
178. Travis, C. C., Quillen, J. L., and Arms, A, D., Pharmokinetics of benzene, Toxicol. Appl. Pharmacol., 102, 400, 1990.
179. Midzenski, M. A., McDiarmid, M. A., Rothinan, N., and Kolodner, K., Acute high dose exposure to benzene in shipyard workers, Am. J. Ind. Med., 22, 553, 1992.
180. Rosenthal, G. J. and Snyder, C. A., Inhaled benzene reduces aspects of cell-mediated tumor surveillance in mice, Toxicol. Appl. Pharmacol., 88, 35, 1987.
181. Aoyama, K., Effects of benzene inhalation on lymphocyte subpopulations and immune response in mice, Toxicol. Appl. Pharmacol., 85, 92, 1986.
182. Lewis, J. G., Odom, B., and Adams, D. O., Toxic effects of benzene and benzene metabolites on mononuclear phagocytes, Toxicol. Appl. Pharmacol., 92, 246, 1988.
183. Rosenthal, G. J. and Snyder, C. A., Modulation of the immune response to listeria monocytogenes by benzene inhalation, Toxicol. Appl. Pharmacol., 80, 502, 1985.
184. Cheung, S. C., Nerland, D. E., and Sonnenfeld, G., Inhibition of interferon gamma production by benzene and benzene metabolites, Natl. Cancer Inst., 80, 1069, 1988.
185. Fan, X., Effect of exposure to benzene on natural killer (NK) cell activity and interleukin-2 (IL-2) production of C57BL/6 mice, J. Nippon Med. Sch., 59, 19, 1992.
186. King, A. G., Landreth, K. S., and Wierda, D., Hydroquinone inhibits bone marrow pre-b cell maturation in vitro, Mol. Pharmacol., 32, 807, 1987.
187. Kellerová, V., Electroencephalographic findings in workers exposed to benzene, J. Hyg. Epidemiol. Microbiol. Immunol., 4, 337, 1985.
188. Choudhary, G., Environmental exposure to 1,3-butadiene: a human health perspective, J. Environ. Sci. Health Part C, 12, 23, 1994.
189. Birnbaum, L. S., A brief survey of butadiene health effects: a role for metabolic differences, Environ. Health Perspect., 101(86), 161, 1993.
190. Bechtold, W. E., Strunk, M. R., Chang, I-Y., Ward, J. B., Jr., and Henderson, R. F., Species differences in urinary butadiene metabolites: comparison of metabolite ratios between mice, rats, and humans, Toxicol Appl. Pharmacol., 127, 44, 1994.
191. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond, J. A., Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation, Carcinogenesis, 15, 1479, 1994.
192. Medinsky, M. A., Leavens, T. L., Csánady, G. A., Gargas, M. L., and Bond, J. A., In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data, Carcinogenesis, 15, 1329, 1994.
193. Thurmond, L. M., Lauer, L. D., House, R. V., Stillman, W. S., Irons, R. D., Steinhagen, W. H., and Dean, J. H., Effect of short-term inhalation exposure to 1,3-butadiene on murine immune functions, Toxicol. Appl. Pharmacol., 86, 170, 1986.
194. Huff, J. E., Melnick, R. L., Solleveld, H. A., Hasemann, J. K., Power, M., and Miller, R. A., Species differences in urinary butadiene metabolites, Science, 277, 548, 1985.
195. Jones, F. E., Toxic Organic Vapors in the Workplace, Lewis Publishers, Boca Raton, 1994, chap. 10.
196. Heck, H. D. A., Casanova, M., and Starr, T. B., Formaldehyde toxicity - new understanding, Crit. Rev. Toxicol., 20, 397, 1990.
197. Chang, C. C. and Gershwin, M. E., Perspectives on formaldehyde toxicity: separating fact from fantasy, Regul. Toxicol. Pharmacol., 16, 150, 1992.
198. Nordman, H., Keskinen, H., and Tuppurainen, M., Formaldehyde asthma - rare or overlooked, J. Allergy Clin. Toxicol., 75, 91, 1985.
199. Kulle, T. J., Sander, L. R., Hebel, J. R., Green, D. J., and Chatham, M. D., Formaldehyde dose-response in healthy non-smokers, J. Air Pollut. Control Assoc., 37, 919, 1987.
200. Patterson, R., Pateras, V., Grammer, L. C., and Harris, K. E., Human antibodies against formaldehyde-human serum albumin conjugates or human serum albumin in individuals exposed to formaldehyde, Int. Arch. Appl. Immunol., 79, 53, 1986.
201. Patterson, R., Dykewicz, M. S., Evans, R., III, Grammer, L. C., Greenberger, P. A., Harris, K. E., Lawrence, I. D., Pruzansky, J. J., Roberts, M., Shaughnessy, M. A., and Zeiss, C. R., IgG antibody against formaldehyde human serum proteins: A comparison with other IgG antibodies against inhalant proteins and reactive chemicals, J. Allergy Clin., Immunol., 84, 359, 1989.
202. Thrasher, J. D., Broughton, A., and Madison, R., Immune activation and autoantibodies in humans with long-term inhalation exposure to formaldehyde, Arch. Environ. Health, 45, 217, 1990.
203. Thrasher, J. D., Wojdani, A., Cheung, G., and Heuser, G., Evidence for formaldehyde antibodies and altered cellular immunity in subjects exposed to formaldehyde in mobile homes, Arch. Environ. Health, 42, 347, 1987.
204. Adams, D. O., Hamilton, T. A., Lauer, L. D., and Dean, J. H., The effect of formaldehyde exposure upon the mononuclear phagocyte system of mice, Toxicol. Appl. Pharmacol., 88, 165-174, 1987.
205. Berglund, B. and Esfandabad, H. S., A bisensory testing procedure suitable for odorous irritants and emissions from building materials, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 107.
206. Chang, J. C. F., Steinhagen, W. H., and Barrow, C. S., Effect of single or repeated formaldehyde exposure on minute volume of BGC3F1 mice and F-344 rats, Toxicol. Appl. Pharmacol., 61, 451, 1981.
207. Green, D. J., Sauder, L. R., Kulle, T. J., and Bascom, R., Acute response to 3.0 ppm formaldehyde in exercising healthy non-smokers and asthmatics. Am. Rev. Respir. Dis., 135, 1261, 1987.
208. Morgan, K. T., Patterson, D. L., and Gross, E. A., Responses of the nasal mucociliary apparatus of F-344 rats to formaldehyde gas, Toxicol. Appl. Pharmacol., 82, 1, 1986.
209. Morgan, K. T., Jiang, X., Z., Starr, T. B., and Kerns, W. D., More precise localization of nasal tumors associated with chronic exposure of F-344 rats to formaldehyde gas, Toxicol. Appl. Pharmacol., 82, 264, 1986.
210. Morgan, K. T., Kimbell, J. S., Monticello, T. M., Patra, A. L., and Fleishman, A., Studies of inspiratory airflow patterns in the nasal passages of the F344 rat and rhesus monkey using nasal molds: relevance to formaldehyde toxicity, Toxicol. Appl. Pharmacol., 110, 223, 1991.
211. Wilmer, J. W. G. M., Woutersen, R. A., Appleman, L. M., Leeman, W. R., and Feron, V. J., Subchronic (13-week) inhalation toxicity study of formaldehyde in male rats: 8-hour intermittent versus 8-hour continuous exposures, Toxicol. Lett., 47, 287, 1989.
212. Falk, J., Juto, J., and Stridh, G., Dose, response study of formaldehyde on nasal mucosa swelling. A study on residents with nasal distress at home, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 585.
213. Recio, L., Sisk, S., Pluta, L., Bermudez, E., Gross, E. A., Chen, Z., Morgan, K., and Walker, C., p53 Mutations in formaldehyde, induced nasal squamous cell carcinomas in rats, Cancer Res., 52, 6113, 1992.
214. Iversen, O. H., Formaldehyde and skin carcinogenesis, Environ. Int., 12, 541, 1986.
215. Saillenfait, A. M., Bonne, P., and DeCeaurriz, J., The effects of maternally inhaled formaldehyde on embryonal and foetal development in rats, Fundam. Chem. Toxicol., 27, 545, 1989.
216. Strubelt, O., Younes, M., Pentz, R., and Kuhnel, W., Mechanistic study on formaldehyde-induced hepatotoxicity, J. Toxicol. Environ. Health, 27, 351, 1989.
217. Dallas, C. E., Badeaux, P., Theiss, J. C., and Fairchild, E. J., The influence of inhaled formaldehyde on rat lung cytochrome P450, Environ. Res., 49, 50, 1989.
218. Green, D. J., Bascom, R., Healey, E. M., Helbel, J. R., Sauder, L. R., and Kulle, T. J., Acute pulmonary response in healthy, non-smoking adults to inhalation of formaldehyde and carbon, J. Toxicol. Environ. Health, 28, 261, 1989.
219. Reuzel, P. G., Wilmer, J. W. G. M., Woutersen, R. A., and Zwart, A., Interactive effects of ozone and formaldehyde on the nasal respiratory lining epithelium in rats, J. Toxicol. Environ. Health, 29, 279, 1990.
220. Ma, T. H. and Harris, M. M., Review of the genotoxicity of formaldehyde, Mutat. Res., 196, 37, 1988.
221. Cosma, G. N. and Marchok, A. C., Benzo[a]pyrene-and formaldehyde-induced DNA damage and repair in rat tracheal epithelial cells, Toxicology, 51, 309, 1988.
222. Craft, T. R., Bermudez, E., and Skopek, T. R., Formaldehyde mutagenesis and formation of DNA, protein crosslinks in human lymphoblasts in vitro. Mutat. Res., 176, 147, 1987.
223. Yager, J. W., Cohn, K. L., Spear, R. C., Fisher, J. M., and Morse, L., Sister-chromatid exchanges in lymphocytes of anatomy students exposed to formaldehyde-embalming solution, Mutat. Res., 174, 135, 1986.
224. Witek, T. J., Jr., Schachter, E. N., Tosun, T., Beck, G. J., and Leaderer, B. P., An evaluation of respiratory effects following exposure to 2.0 ppm formaldehyde in asthmatics: lung function, symptoms, and airway reactivity, Arch. Environ. Health, 42, 230, 1987.
225. Anderson, R. C. and Coogan, P. F., Bioassay of indoor air for irritant effects. Environ. Technol., 15, 813, 1994.
226. Tepper, J. S. and Costa, D. L., Will the mouse bioassay for estimating sensory irritancy of airborne chemicals (ASTM E 981-84) be useful for evaluation of indoor air contaminants, Indoor Environ., 1, 367, 1992.
227. Tepper, J. S., Moser, V. C., Costa, D. L., Mason, M. A., Roache, N., Guo, Z., and Dyer, R. S., Toxicological and chemical evaluation of emissions from carpet samples. Am. Ind. Hyg. Assoc. J., 56, 158, 1995.
228. Muller, W. C. and Black, M. S., Sensory irritation in mice exposed to emissions from indoor products, Am. Ind. Hyg. Assoc. J., 56, 794, 1995.
229. Stadler, J. C., Dudek, B. R., Kaempfe, T. A., Christoph, G. R., and Hasten, J. F., Evaluation of a method used to test for potential toxicity of carpet emissions, Fundam. Chem. Toxicol., 32, 1073, 1994.
230. Wolkoff, P., Nielsen, Hansen, G. D., Albrechtsen, O., Johnsen, C. R., Heinig, J. H., and Frank, C., A study of human reactions to emissions from building materials in climatic chambers. Part II: VOC measurements, mouse bioassay, and decipol evaluation in the 1-2 mg m-3 TVOC range, Indoor Air, 1, 389, 1991.
231. Zingg, M. and Kaenel, M., Quick possibility of clarifying indoor-loads of stretch-carpets, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 6, Helsinki, Finland, 1993, 663.
232. Norbäck, D., Edling, C., Wieslander, G., and Ramadhan, S., Exposure to volatile organic compounds (VOC) in the general Swedish population and its relation to perceived air quality and the sick building syndrome, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 573.
233. Mølhave, L., Volatile organic compounds, indoor air quality and health, in Indoor Air '90, Proc. 5th Int. Conf. on Indoor Air Quality and Climate, Vol. 5, Intternational Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 15.
234. Hudnell, H., Otto, D., House, D., and Moølhave, L., Odor and irritation effects of a volatile organic compound mixture, in Proc. Indoor Air '90, 5th Int. Conf. Indoor Air Quality and Climate, Vol. 1, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 263.
235. Hudnell, H. K., Otto, D. A., House, D. E., Mølhave, L., Exposure of humans to a volatile organic mixture. II. Sensory, Arch. Environ. Health, 47, 31, 1992.
236. Hudnell, H. K., Otto, D. A., and House, D. E., Time course of odor and irritation effects in humans exposed to a mixture of 22 volatile organic compounds, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 567.
237. Otto, D. A., Mølhave, L., Hudnell, H. K., Goldstein, G., and O'Neil, J., Neurotoxic effects of controlled exposure to a complex mixture of volatile organic compounds, Final report 2520, U.S. Environmental Protection Agency, 1990.
238. Otto, D., Mølhave, L., Rose, G., Hudnell, H. K., and House, D., Neurobehavioral and sensory irritant effects of controlled exposure to a complex mixture of volatile organic compounds, Neurotoxicol. Teratol., 12, 649, 1990.
239. Otto, D., Hudnell, H. K., House, D., Mølhave, L., and Counts, W., Exposure of humans to a volatile organic mixture. I. Behavioral assessment, Arch. Environ. Health, 47, 23, 1992.
240. Otto, D., Hudnell, H. K., and Prah, J., Methodological issues in human exposure studies of low level solvent mixtures, Appl. Psychol. Int. Rev., 41, 239, 1992.
241. Otto, D., Hudnell, H. K., House, D., and Prah, J., Neurobehavioral and subjective reactions of young men and women to a complex mixture of volatile organic compounds, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 59.
242. Mølhave, L., Bach, B., and Pedersen, O. F., Human reactions to low concentrations of volatile organic compounds, Environ. Int., 8, 337, 1986.
243. Girman, J. R., Alevantis, L. E., Petreas, M. X., and Webber, L. M., Building bake-out studies, in Indoor Air '90: Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 3, Ottawa, Canada, 1990, 349.
244. Offerman, F. J., Loiselle, S. A., Ander, G. D., and Lau, H., Indoor contaminant emission rates before and after a building bake-out, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 6, Helsinki, Finland, 1993, 687.
245. Borrazo, J. and Girman, J., Temperature effects in building bake-out, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 6, Helsinki, Finland, 1993, 575.
246. Koren, H., Devlin, R., House, D., Steingold, S., and Graham, D., The inflammatory response of the human upper airways to volatile organic compounds (VOC), in Proc. Indoor Air '90, Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 1, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 325.
247. Koren, H., Graham, D. E., and Devlin, R. B., Exposure of humans to a volatile organic mixture. III. Inflammatory response, Arch. Environ. Health, 47, 39, 1992.
248. Kjaergaard, S., Mølhave, L., and Pedersen, O. F., Human reaction to a mixture of indoor air volatile organic compounds, Atmos. Environ., 25 A, 1417, 1991.
249. Gell, P. H. G. and Coombs, R. R. A., Clinical Aspects of Immunology, Blackwood Scientific Press, Oxford, England, 1975.
250. Bakke, J. V., Aas, K., Andersen, I., Knudsen, B. B., Lindvall, T., Nordman, H., and Wahlberg, J. E., NKB-Report on chemicals and hypersensitivity in the airways. I: Classification of chemicals, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993a, 141.
251. Bakke, J. V., Aas, K., Andersen, I., Knudsen, B. B., Lindvall, T., Nordman, H., and Wahlberg, J. E., NKB-Report on chemicals and hypersensitivity in the airways. II: Known and suspected initiators of asthma and potential harmful exposures, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 147.
252. Ingram, R. H., Jr., Asthma and airway hypersensitivity, Annu. Rev. Med., 42, 139, 1991.
253. Barnes, P. J., Anti-inflammatory therapy for asthma, Annu. Rev. Med., 44, 229, 1993.
254. Morley, J., Immunopharmocology of asthma, Immunol. Today, 14, 317, 1993.
255. Mudde, G. C., Bheekha, R., and Bruijnzeel-Koomen, C. A. F. M., Consequences of IgE/CD23-medicated antigen presentation in allergy, Immunol. Today, 16, 380, 1995.
256. Poulter, L. W., Jannossg, G., Power, C., Sreenan, S., and Burke, C., Immunological/physiological relationship in asthma: potential regulation by lung macrophages, Immunol. Today, 15, 258, 1994.
257. Sussman, G. L. And Breezhold, E. H., Allergy to latex rubber, Ann. Int. Med., 122, 43, 1995.
258. Fink, J. N., Latex allergy, Immunol. Allergy Clin. N. Am., 15, 1995.
259. Slater, J., Latex allergy, J. Allergy Clin. Immunol., 94, 139, 1994.
260. Swanson, M., Bubak, M., Hunt, L., Yunginger, J. W., Warner, M., and Reed, C., Quantification of occupational latex aeroallergens in a medical center, J. Allergy Clin. Immunol., 94, 445, 1994.
261. Tomazk, V. J., Shampaine, E. L., Lamanna, A., Withrow, T. J., Adkinson, N. F., Jr., and Hamilton, R. A., Cornstarch powder on latex products is an allergen carrier, J. Allergy Clin. Immunol., 93, 751, 1994.
262. Breezhold, D. H., Sussman, G. L., Kostyal, D. A., and Chang, N. S., Identification of a 46-kD latex protein allergen in health care workers, Clin. Exp. Immunol., 98, 408, 1994.
263. Meggs, W. J., Neurogenic inflammation and sensitivity to environmental chemicals, Environ. Health Perspect., 101, 234, 1993.
264. Kimber, I. and Basketter, D. A., The murine local lymph node assay: a commentary on collaborative studies and new directions, Fundam. Chem. Toxicol., 30, 165, 1992.
265. Cozens, P. J. and Rowe, F. M., Substance P is a potent inducer of TNF and IL-1 secretion by macrophages: a potent role for TNF in the pathogenesis of asthma, Immunobiology, 175, 7, 1987.
266. Hurst, S. M., Stanisz, A. M., Sharkey, K. A., and Collins, S. M., Interleukin 1ß-induced increase in substance P in rat myenteric plexus, Gastroenterology, 105, 1754, 1993.
267. Shadiack, A. M., Carlson, C. D., Ding, M., Hart, R. P., and Jonakait, G. M., Lipopolysaccharide induces substance P in sympathetic ganglia via ganglionic interleukin-1 production, J. Neuroimmunol., 49, 51, 1994.
268. Freidin, M. and Kessler, J. A., Cytokine regulation of substance P expression in sympathetic neurons, Proc. Natl. Acad. Sci. U.S.A., 88, 3200, 1991.
269. Vasko, M. R., Campbell, W. B., and Waite, K. J., Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture, J. Neurosci., 14, 4987, 1994.
270. Garry, M. G., Richardson, J. D., and Hargreaves, K. M., Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric-oxide independent mechanisms, J. Neurosci., 14, 4329, 1994.
271. Pascual, D. W. and Bost, K. L., Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide, J. Immunol., 71, 52, 1990.
272. Weinstock, J. V. and Blum, A. M., Tachykinin production in granulomas of murine Schistomiasis mansoni, J. Immunol., 142, 3256, 1989.
273. Cook, G. A., Elliott, D., Metwali, A., Blum, A. M., Sandor, M., Lynch, R., and Weinstock, J. V., Molecular evidence that granuloma T lymphocytes in murine Schistosomiasis mansoni express an authentic substance P (NK-1) receptor, J. Immunol., 152, 1830, 1994.
274. Nieber, K., Baumgarten, C., Witzel, A., Rathsack, R., Oehme, P., Brunnee, T., Kleine, Tebbe, J., and Kunkel, G., The possible role of substance P in the allergic reaction, based on two different provocation models, Int. Arch. Applied Immunol., 94, 334, 1991.
275. DeRose, V., Robbins, R. A., Snider, R. M., Spurzem, J. R., Thiele, G. M., Rennard, S. I., and Rubinstein, I., Substance P increases neutrophil adhesion to bronchial epithelial cells, J. Immunol., 152, 1339, 1994.
276. Okamoto, Y., Shirotori, K., Kudo, K., Ishikawa, K., Ito, E., Togawa, K., and Saito I., Cytokine expression after the topical administration of substance P to human nasal mucosa, J. Immunol., 151, 4391, 1993.
277. Chaen, T., Watanabe, N., Mogi, G., Mori, K., and Takeyama, M., Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy, Ann. Otol. Rhinol. Laryngol., 102, 16, 1993.
278. Kavelaars, A., Broeke, D., Jeurissen, F., Karclux, J., Meijer, A., Franklin, R., Gelfand, E. W., and Heijnen, C. J., Activation of human monocytes via a non-neurokinin substance PP receptor that is coupled to G: protein, calcium, phospholipase D, MAP kinase and IL-6 production, J. Immunol., 153, 3691, 1994.
279. Payan, D. G., Brewster, D. R., and Goetzl, E. J., Specific stimulation of human T lymphocytes by substance P, J. Immunol., 131, 1613, 1983.
280. Stanisz, A. M., Befus, D., and Bienenstock, J., Differential effects of vasoactive intestinal peptide, substance P. and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patch, mesenteric lymph nodes and spleen, J. Immunol., 136, 153, 1986.
281. Dearman, R. J. and Kimber, I., Divergent immune responses to respiratory and contact chemical allergens: antibody elicited by phthalic anhydride and oxazolone, Clin. Exp. Allergy, 22, 241, 1992.
282. Tepper, R., Levinson, D. A., Stanger, B. Z., Campos, Torres, J., Abbas, A. K., and Leder, P., IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice, Cell, 62, 457, 1990.
283. Finkelman, F. D., Katona, I. M., Mosmann, T. R., and Coffman, R. L., IFN-n regulates the isotypes of Ig secreted during in vivo humoral immune responses, J. Immunol., 140, 1022, 1988.
284. Snapper, C. M. and Paul, W. E., Interferon-y and B cell stimulating factor-1 reciprocally regulate Ig isotype production. Science, 236, 944, 1987.
285. Coffman, R. L., Lebman, D. A., and Rothman, P., Mechanism and regulation of immunoglobulin isotype switching, Adv. Immunol., 54, 229, 1993.
286. Schwartz, A., Grabbe, S., Reimann, H., Aragane, Y., Simon, M., Manon, S., Andrade, S., Luger, T. A., Zlotnik, A., and Swartz, T., In vivo effects of interleukin-10 on contact hypersensitivity and delayedtype hypersensitivity reactions, J. Invest. Dermatol., 103, 211, 1994.
287. Dearman, R. J., Basketter, D. A., and Kimber, I., Variable effects of chemical allergens on serum IgE concentration in mice. Preliminary evaluation of a novel approach to the identification of respiratory sensitizers, Appl. Toxicol., 12, 317, 1992.
288. Dearman, R. J., Hegarty, J. M., and Kimber, I., Inhalation exposure of mice to trimellitic anhydride induces both IgG and IgE ami, hapten antibody, Int. Arch. Allergy Appl. Immunol., 95, 70, 1991.
289. Dearman, R. J., Mitchell, J. A., Basketter, D. A., and Kimber, I., Differential ability of occupational chemical contact and respiratory allergens to cause immediate and delayed dermal hypersensitivity reactions in mice, Int. Arch. Allergy Appl. Immunol., 97, 315, 1992.
290. Dearman, R. J., Spence, L. M., and Kimber, I., Characterization of murine immune responses to allergenic diisocyanates, Toxicol. Appl. Pharmacol., 112, 190, 1992.
291. Holliday, M. R., Coleman, J. W., Dearman, R. J., and Kimber, I., Induction of mast cell sensitization by chemical allergens: a comparative study, J. Appl. Toxicol., 13, 137, 1993.
292. Hayes, J. P., Daniel, R., Tee, R. D., Barnes, P. J., Chung, K. F., and Newman Taylor, A. J., Specific immunological and bronchopulmonary responses following intradermal sensitization to free trimellitic anhydride in guinea pigs, Clin. Exp. Allergy, 22, 694, 1992.
293. Bernstein, D. I., Korbee, L., Stauder, T., Bernstein, J. A., Scinto, J. Herd, Z. L., and Bernstein, I. L., Clinical aspects of allergic disease: the low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to disocyanates, J. Allergy Clin. Immunol., 92, 387, 1993.
294. Patterson, R., Harris, K. E., Stopford, W., Van der Heiden, G., Grammer, L. C., and Bunn, W., Irritant symptoms and immunologic responses to multiple chemicals: importance of clinical and immunologic correlations, Int. Arch. Allergy Appl. Immunol., 85, 467, 471, 1988.
295. Karol, M. H., Comparison of clinical and experimental data from an animal model of pulmonary immunologic sensitivity, Ann. Allergy, 66, 485, 1991.
296. Basketter, D. A. Scholes, E. W., Kimber, I., Botham, P. A., Hilton, J., Miller, K., Robbins, M. C., Harrison, P. T. C., and Waite, J., Interlaboratory evaluation of the local lymph node assay with 25 chemicals and comparison with guinea pig test data, Toxicol. Methods, 1, 30, 1991.
297. Basketter, D. A., Scholes, E. W., Kimber, I., Botham, P. A., Hilton, J., Miller, K., Robbins, M. C., Harrison, P. T. C., and Waite, S. J., Sulphanilic acid: divergent results in the guinea pig maximization test and the local lymph node assay, Contact Dermatitis, 27, 209, 1992.
298. Dearman, R. J., Hope, J. C., Hopkins, S. J., Debicki, R. J., and Kimber, I., Interleukin 6 (IL-6) production by lymph node cells: an alternative endpoint for the murine local lymph node assay, Toxicol. Methods, 3, 268, 1993.
299. Descotes, J., Tedone, R., and Evreux, J. C., Immunotoxicity screening of drugs and chemicals: value of contact hypersensitivity to picryl chloride in the mouse, Methods Findings Exp. Clin. Pharmacol., 7, 303, 1985.
300. Friedmann, P. S., Strickland, I., Memon, A. A., and Johnson, P. M., Early time course of recruitment of immune surveillance in human skin after chemical provocation, Clin. Exp. Immunol., 91, 351, 1993.
301. Muller-Decker, K., Furstenberger, G., and Marks, F., Keratinocyte, derived proinflammatory key mediators and cell viability as in vitro parameters of irritancy: a possible alternative to the Draize skin irritation test, Toxicol. Appl. Pharmacol., 127, 99, 1994.
302. White, K. L., Sanders, V. M., Barnes, D. W., Shopp, G. M., Jr., and Munson, A. E., Immunotoxicology investigations in the mouse: general approach and methods, Drug Chem. Toxicol., 8, 299, 1985.
303. Luster, M. I., Munson, A. E., Thomas, P. T., Holsapple, M. P., Fenters, J. D., White, K. L., Jr., Lauer, L. D., Germolec, D. R., Rosenthal, G. J., and Dean, J. H., Development of a testing battery to assess chemical-induced immunotoxicity: national toxicology program's guidelines for immunotoxicity evaluation in mice, Fundam. Appl. Toxicol., 10, 2, 1988.
304. Exon, J. H., Koller, L. D., Talcott, P. A., O'Reilly, C. A., and Henningsen, G. M., Immunotoxicity testing: an economical multiple, assay approach, Fundam. Appl. Toxicol., 7, 387, 1986.
305. Hinton, D. M., Testing guidelines for evaluation of the immunotoxic potential of direct food additives, Crit. Rev. Food Sci. Nutr., 32, 173, 1992.
306. NRC (U.S.) Biological Markers in Immunotoxicology, National Research Council National Academy Press, 1992.
307. Sarlo, K. and Clark, E. D., A tier approach for evaluating the respiratory allergenicity of low molecular weight chemicals, Fundam. Appl. Toxicol., 18, 107, 1992.
308. Luster, M. L, Portier, C., Fait, D. G., White, K. L., Jr., Gennings, C., Munson, A. E., and Rosenthal, G. J., Risk Assessment in immunotoxicology. I. Sensitivity and predictability of immune tests, Fundam. Appl. Toxicol., 18, 200, 1992.
309. Dietert, R. R., Golemboski, K. A., and Austic, R. E., Environment-immune interactions. Poultry Sci., 73, 1062, 1994.
310. Rees, D. C., Francis, E. Z., and Kimmel, C. A., Qualitative and quantitative comparability of human and animal developmental neurotoxicants: a workshop summary, Neurotoxicology, 11, 257, 1990.
311. Rees, D. C., Francis, E. Z., and Kimmel, C. A., Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: an overview, Neurotoxicol. Teratol., 12, 175, 1990.
312. Lewis, T. R., Morrow, P. E., McClellan, R. O., Raabe, O. G., Kennedy, G. L., Scwetz, B. A., Goehl, T. J., Roycroft, J. H., and Chhabra, R. S., Establishing aerosol exposure concentrations for inhalation toxicity studies, Toxicol. Appl. Pharmacol., 99, 377, 1989.
313. Nielsen, G. D. and Alarie, Y., Animal assays for upper airway irritation: screening of materials and structure -activity relations, Ann. N.Y. Acad. Sci., 641, 164, 1992.
314. Dahl, A. R., Damon, E. G., Mauderly, J. L. Rothenberg, S. J., Seiler, F. A., and McClellan, R. O., Uptake of 19 hydrocarbon vapors inhaled by F344 rats, Fundam. Applied Toxicol., 10, 262, 1988.
315. Herman, D. C., Inniss, W. E., and Mayfield, C. I., Impact of volatile aromatic hydrocarbons, alone and in combination, on growth of the freshwater alga Selenastrum capricomutum, Aquat. Toxicol., 18, 87. 1990.
316. Medinsky, M. A., Kimbell, J. S., Morris, J. B., Gerde, P., and Overton, J. H., Advances in biologically based models for respiratory tract uptake of inhaled volatiles, Fundam. Appl. Toxicol., 20, 265, 1993.
317. Johanson, G., Modelling of respiratory exchange of polar solvents, Ann. Occup. Hyg., 35, 323, 1991.
318. Gravesen, S., Ipsen, H., and Skov, P., Partial characterization of the components in the macromolecular organic dust (Mod) fraction and their possible role in the sick building syndrome (SBS), in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate. Vol. 4, Helsinki, Finland, 1993, 33.
319. Lippmann, M., Use of human lung tissue for studies of structural changes associated with chronic ozone exposure: opportunities and critical issues, Environ. Health Perspect., 104 (Suppl. 4), 209, 1993.
320. Bates, D. V., Detection of chronic respiratory bronchiolitis in oxident-exposed populations: analogy to tobacco smoke exposure, Environ. Health Perspect., 101 (Suppl. 4), 217, 1993.
321. Friedinan, M., Madden, M. C., Samet, J. M., and Koren, H. S., Effects of ozone exposure on lipid metabolism in human alveolar machrophages, Environ. Health Perspect., 97, 95, 1992.
322. Devlin, R. B., McDonnell, W. F., Mann, R., Becker, S., House, D. E., Schreinemachers, D., and Karen, H. S., Exposure of human to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung, Am. J. Respir. Cell. Mol. Biol., 4, 72, 1991.
323. Silnour, M. I., Park, P., and Selgrade, M. K., Ozone-enhanced pulmonary infection with Streptococcus Zooepidemics in mice, Am. Rev. Respir. Dis., 147, 753, 1993.
324. Banks, M. A., Porter, D. W., Martin, W. G., and Castranova, V., Effects of in vitro ozone exposure on peroxidative damage, membrane leakage, and taurine content of rat alveolar macrophages, Toxicol. Appl. Pharmacol., 105, 55, 1990.
325. Oosting, R. S., van Golde, L. M. G., Verhoef, J., and van Bree, L., Species differences in impairment and recovery of alveolar macrophage functions following single and repeated ozone exposures, Toxicol. Appl. Pharmacol., 110, 170, 1991.
326. Li, A. F. Y. and Richters A., Ambient level ozone effects on subpopulations of thymocytes and spleen T lymphocytes, Arch. Environ. Health, 46, 57, 1991.
327. Selgrade, M. J. K., Daniels, M. J., and Grose, E. C., Acute, subchronic, and chronic exposure to a simulated urban profile of ozone: effects on extrapulmonary natural killer cell activity and lymphocyte mitogenic responses, Inhal. Toxicol., 2, 375, 1990.
328. Burleson, G. R., Keyes, L. L., and Stutzman, J. D., Immunosuppression of pulmonary natural killer activity by exposure to ozone, Immunopharmacol. Immunotoxicol., 11, 715, 1989.
329. ASHRAE, Ventilation for acceptable indoor air quality, ASHRAE Standard 62-1989, ASHRAE, Atlanta, GA, 1989.
330. Iwashita, G., Assessment of Indoor Air Quality Based on Human Olfactory Sensation, Ph.D. thesis, Waseda University, 1992.
331. Hedge, A., Erickson, W. A., and Rubin, G., The effects of alternative smoking policies on indoor air quality in 27 office buildings, Ann. Occup. Hyg., 38, 265, 1994.
332. Bardana, E. J., Jr., Montanaro, A., and O'Hollaren, M. T., Building-related illness: a review of available scientific data, Clin. Rev. Allergy, 6, 61, 1988.
333. Wallace, L. A., Nelson, C. J., and Dunteman, G., Workplace characteristics associated with health and comfort concerns in three office buildings in Washington D.C., in IAQ '91, Healthy Buildings, ASHRAE, Atlanta, 56, 1991.
334. Hedge, A., Erickson, W., and Rubin, G., Effects of personal and occupational factors on sick building syndrome reports in air conditioned offices, in Work and Well-Being: Assessments and Interventions for Occupational Mental Health, Quick, J. C., Murphy, L. R., and Hurrell, J. J., Jr., Eds., American Psychological Association, Washington, D.C., 1992, chap. 19.
335. Hedge, A., Erickson, W. A., and Rubin, G., Psychosocial correlates of sick building syndrome, Indoor Air, in press, 1994.
336. Sundell, J., On the association between building ventilation characteristics, some indoor environmental exposures, some allergic manifestations, and subjective sympton reports. Indoor Air, Suppl. 2, 148, 1994.
337. Mølhave, L., Volatile organic compounds, indoor air quality, and health, Indoor Air, 1, 357, 1991.
338. Cain, W. S. and Cometto-Muniz, J. E., Irritation and odor symptoms of indoor air pollution, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 21.
339. Fanger, P. O., Introduction of the olf and decipol units to quantify air pollution perceived by humans indoors and outdoors. Energy Build., 12, 1, 1988.
340. Fanger, P. O., The new comfort equation for indoor air quality, ASHRAE J., October, 33, 1989.
341. Lehrner, J. P., Gender differences in long-term odor recognition memory: verbal versus sensory influences and the consistency of label use, Chem. Senses, 18, 17, 1993.
342. Lorig, T. S., Human EEG and odor response, Prog. Neurobiol., 33, 387, 1989.
343. Lorig, T. S., Herman, K. B., Schwartz, G. E., and Cain, W. S., EEG activity during administration of low-concentration odors, Bull. Psychonom. Soc., 28, 405, 1990.
344. Lorig, T. S., Huffman, E., deMartino, A. G., and DeMarco, J., EEG and behavioral responses to low-level galaxolide administration, Chem. Senses, 14, 723, 1989.
345. Lorig, T. S., Schwartz, G. E., Herman, K. B., and Lane, R. D., Brain and odor. II. EEG activity during nose and mouth breathing, Psychobiology, 16, 285, 1988.
346. Lorig, T. S. and Schwartz, G. E., Brain and odor: I. alteration of human EEG by odor administration, Psychobiology, 16, 281, 1988.
347. Carrasco, M. and Ridout, J. B., Olfactory perception and olfactory imagery: a multidimensional analysis, J. Exp. Psychol. Hum. Percept. Perform., 19, 287, 1993.
348. Lorig, T. S. and Roberts, M., Odor and cognitive alteration of the contingent negative variation, Chem. Senses, 15, 537, 1990.
349. Lorig, T. S., Mayer, T. S., Moore, F. H., and Warrenburg, S., Visual event-related potentials during odor labeling, Chem. Senses, 18, 379, 1993.
350. Lorig, T. S., Sapp, A. C., Campbell, J., and Cain, W. S., Event-related potentials to odor stimuli, Bull. Psychonom. Soc., 31, 131, 1993.
351. Knasko, S. C., Gilbert, A. N., and Sabini, J., Emotional state, physical well-being, and performance in the presence of feigned ambient odor, J. Appl. Soc. Psychol., 20, 1345, 1990.
352. Knasko, S. C., Ambient odor's effect on creativity, mood, and perceived health, Chem. Senses, 17, 27, 1992.
353. Kullman, G. J. and Sanderson, W. T., Health Hazard Evaluation, No. MHETA-88-020-1908, University of South Florida, Tampa, FL, Mining Health Evaluation and Technical Assistance Program, NIOSH, U.S. Department Health and Human Services, Morgantown, WV, 1988.
354. Hales, T. and Daniels, W., Hazard Evaluation and Technical Assistance, No. HETA, 89, 068, L2039, Wichita County Department of Social and Rehabilitative Services, Wichita, KS, Hazard Evaluations and Technical Assistance Branch, NIOSH, U.S. Department of Health and Human Services, Cincinnati, OH, 1990.
355. Ziem, G. E. and Castleman, B. I., Threshold limit values: historical perspectives and current practice, J. Occup. Med., 31, 910, 1989.
356. Jensen, B., Wolkoff, P., and Wilkins, C. K., Characterization of linoleum. Part 2: preliminary odor evaluation, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 2, 1993, 449.
357. Winfield, M., A case history: odor and health problems in a Texas public school building, in IAQ '87: Practical Control of Indoor Air Problems, Proc. ASHRAE Conf. 18-20 May, Arlington, VA, ASHRAE, Atlanta, GA, 1987, 111.
358. McNicol, D., The use of signal detection theory in the evaluation of information displays, in Information Design, Easterby, R. and Zwaga, H., Eds., J. Wiley and Sons, London, 1984, chap. 5.
359. Staudenmayer, H., Seiner, J. C., and Buhr, M. P., Double-blind provocation challenges in 20 patients presenting with "multiple chemical sensitivity", Regul. Toxicol. Pharmacol., 18, 44, 1993.
360. European Concerted Action (COST 613) Report No. 11, Guidelines for Ventilation Requirements in Buildings, Commission of the European Communities, Luxembourg, 1992.
361. Indoor Air Pollutants: Exposure and Health Effects, EURO Reports and Studies 78, World Health Organization, 1983.
362. Wilson, S. and Hedge, A., The Office Environment Survey: A Study of Building Sickness, Building Use Studies Ltd., London, U.K., 1987.
363. Burge, P. S., Robertson, A. S., and Hedge, A., Surveillance of office buildings using the workforce to measure the building symptom index (BSI), a measure of the sick building syndrome, in Indoor Air '93: Health Effects, Proc. 6th Int. Conf .Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 731.
364. Skov, P., Valbjørn, O., Pederson, B. V., and DISG (Danish Indoor Climate Study Group), Influence of indoor climate on the sick building syndrome in an office environment, Scand. J. Work Environ. Health, 16, 363, 1990.
365. Norbäck, D. and Torgen, M., A longitudinal study relating carpet with sick building syndrome, Environ. Int., 15, 129, 1989.
366. Nörback, D., Edling, C., Wieslander, G., and Ramadhan, S., Exposure to volatile organic compounds (VOC) in the general Swedish population and its relation to perceived air quality and the sick building syndrome, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, Helsinki, Finland, 1993, 573.
367. Zweers, T., Preller, L., Brunekreef, B., and Boleij, J. S. M., Relationships between health and indoor climate complaints and building, workplace, job, and personal characteristics, in Indoor Air '90, Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 1, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 495.
368. Zweers, T., Preller, L., Brunekreef, B., and Boleij, J. S. M., Health and indoor climate complaints of 7043 office workers in 61 buildings in the Netherlands, Indoor Air, 2, 127, 1992.
369. Sundell, J., Andersson, B., Andersson, K., and Lindvall, T., Volatile organic compounds in ventilating air in buildings at different sampling points in the buildings and their relationship with the prevalence of occupant symptoms, Indoor Air, 3, 82, 1993.
370. Munby, J., Smy, J. R., Weetman, D. F., and Keany, N. P., Health effects associated with re-carpeting and painting an academic library. Selected abstracts of the Int. Conf. on Priorities for Indoor Air Research and Action, Indoor Environ., 1, 44, 1991.
371. Hedge, A., Questionnaire design guidelines for investigations of "sick buildings", in Indoor Air '90: Proc. 5th Int. Conf. Indoor Air Quality and Climate, Vol. 1, International Society for Indoor Air Quality and Climate, Ottawa, Canada, 1990, 605.
372. Mitchell, A. A., Cottler, L. B., and Shapiro, S., Effect of questionnaire design on recall of drug exposure in pregnancy, Am. J. Epidemiol., 123, 670, 1986.
373. Pennebaker, J. W., The Psychology of Physical Symptoms, Springer-Verlag, New York, 1982.
374. Solvason, H. B., Ghanta, V. K., Lorden, J. F., Soong, S-J., and Hiramoto, R. N., A behavioral augmentation of natural immunity: odor specificity supports a Pavlovian conditioning model. Int. J. Neurosci., 61, 277, 1991.
375. Bolla-Wilson, K., Wilson, R. J., and Bleecker, M. L., Conditioning of physical symptoms after neurotoxic exposure, J. Occup. Med., 30, 684, 1988.
376. Göthe, C. J., Ancker, K., Bjurström, R., Holm, S., and Langworth, S., Relative humidity, temperature and subjective perception of "dry air", in Indoor Air '87, Proc. 4th Int. Conf. Indoor Air Quality and Climate, Vol. 3, Siefert, B., Esdon, H., Fischer, M., Ruden, H., and Wegner, J., Eds., Institute for Water, Soil and Air Hygiene, Berlin (West), 1987, 443.
377. Pennebaker, J. W. and Skelton, J. A., Selective monitoring of bodily sensations, J. Pers. Soc. Psychol., 41, 213, 1981.
378. Colligan, M. J. and Murphy, L. R., A review of mass psychogenic illness in work settings, in Mass Psychogenic Illness: A Social Psychological Analysis, Colligan, M. J., Pennebaker, J. W., and Murphy, L. R., Eds., Erlbaum, New Jersey, 1982, chap. 3.
379. Colligan, M. J. and Smith, M. J., A methodological approach for evaluating outbreaks of mass psychogenic illness in industry, J. Occup. Med., 20, 401, 1978.
380. Boxer, P. A., Indoor air quality: a psychosocial perspective, J. Occup. Med., 32, 425, 1990.
381. Olkinuora, M., Psychogenic epidemics and work, Scand. J. Work Environ. Health, 10, 501, 1984.
382. Boxer, P. A., Occupational mass psychogenic illness: history, prevention, and management, J. Occup. Med., 27, 867, 1985.
383. Colligan, M. J. and Murphy, L. R., A methodological approach for evaluating outbreaks of mass psychogenic illness in industry, J. Occup. Med., 20, 401, 1978.
384. Stuewing, J. P. and Gray, C. C., An epidemic of respiratory complaints exacerbated by mass psychogenic illness in a military recruit population. Am. J. Epidemiol., 132, 1120, 1990.
385. Rea, W. J., Chemical Sensitivity: Principles and Mechanisms, Vols. 1 & 2, Lewis Publishers, Boca Raton, FL, 1992.
386. Ziem, G. E., Multiple chemical sensitivity: treatment and follow-up with avoidance and control of chemical exposures, Toxicol. Ind. Health, 8, 73, 1992.
387. Hileman, B., Multiple chemical sensitivity, Chem. Eng. News, July 22, 26, 1991.
388. Barrett, S., Unproven "allergies": an epidemic of nonsense, Nutr. Today, March/April, 6, 1989.
389. Barrett, S., Unproven "Allergies": An Epidemic of Nonsense, American Council on Science and Health, New York, 1993.
390. Orne, T. and Benedetti, P., Multiple Chemical Sensitivity, American Council on Science and Health, New York, 1994.
391. Terr, A. I., Clinical ecology, Ann. Intern. Med., 111, 168, 1989.
392. Brautbar, N., Vojdani, A., and Campbell, A. W., Multiple chemical sensitivities - fact or myth. Guest editorial, Toxicol. Ind. Health, 8, v-xiii, 1992.
393. Black, D. W., Rathe, A., and Goldstein, R. B., Environmental illness: a controlled study of 26 subjects with '20th Century Disease', J. Am. Med. Assoc., 264, 3166, 1990.
394. Hall, S. K., The worker with chemical hypersensitivity syndrome, Pollut. Eng., 76, 79, 1989.
395. Simon, G. E., Katon, W. J., and Sparks, P. J., Allergic to life: psychological factors in environmental illness, Am. J. Psychiatr., 147, 901, 1990.
396. Bell, I. R., Schwartz, G. E., Peterson, J. M., Amend, D., and Stini, W. A., Possible time-dependent sensitization to xenobiotics: self-reported illness from chemical odors, foods, and opiate drugs in an older adult population. Arch. Environ. Health, 48, 315, 1993.
397. Terr, A., Environmental illness: a clinical review of 50 cases. Arch. Intern. Med., 146, 145, 1986.
398. Simon, G. E., Daniell, W., Stockbridge, H., Claypoole, K., and Rosenstock, L., Immunological, psychological and neuropsychological factors in multiple chemical sensitivity, Ann. Intern. Med., 119, 97, 1993.
399. Miller, C. S., The hypersusceptible individual, in Indoor Air '93: Proc. 6th Int. Conf. Indoor Air Quality and Climate, Vol. 1, 1993, 549.
400. Hedge, A., Suggestive evidence for a relationship between office design and self-reports of ill-health among office workers in the United Kingdom, J. Archil. Planning Res., 1, 163, 1984.
401. Robertson, A. S., Burge, P. S., Hedge, A., Sims, J., Gill, F. S., Finnegan, M., Pickering, C. A. C., and Dalton, G., Comparison of health problems related to work and environment measurements in two office buildings with different ventilation systems, Br. Med. J., 291, 373, 1985.
402. Burge, P. S., Hedge, A., Wilson, S., Harris-Bass, J., and Robertson, A. S., Sick building syndrome: a study of 4373 office workers, Ann. Occup. Hyg., 31, 493, 1987.
403. Hedge, A., Burge, P. S., Wilson, A. S., and Harris-Bass, J., Work-related illness in office workers: a proposed model of the sick building syndrome, Environ. Int., 15, 143, 1989.
404. Mendell, M. J., Non-specific symptoms in office workers: a review and summary of the epidemiologic literature. Indoor Air, 3, 227, 1993.
405. Mendell, M. J. and Smith, A. H., Consistent pattern of elevated symptoms in air conditioned office buildings. Am. J. Public Health, 80, 1193, 1990.
406. Hedge, A., Environmental conditions and health in offices. Int. Rev. Ergonom., 3, 87, 1989.
407. Morris, L. and Hawkins, L., The role of stress in the sick building syndrome, in Indoor Air '87, Proc. 4Th Int. Conf. Indoor Air Quality and Climate, Vol. 2, Siefert, B., Esdon, H., Fischer, M., Ruden, H., and Wegner, J., Eds., Institute for Water Soil and Air Hygiene, Berlin (West), 1987, 566.
408. Hedge, A., Job stress, job satisfaction, and work-related illness in offices, in Proc. 32nd Ann. Meet. Human Factors Society, Human Factors Society, Santa Monica, 1988, 777.
409. Skov, P., Valbjørn, O., Pederson, B. V., and DISG (Danish Indoor Climate Study Group), Influence of personal characteristics, job related factors and psychosocial factors on the sick building syndrome, Scand. J. Work Environ. Health, 15, 286, 1989.
410. Hedge, A. and Erickson, W.A., Predicting sick building syndrome at the individual and aggregate levels, Environ. Int., 22, 1, 3, 1996.
411. Krankenhauser, M. and Johansson, G., Stress at work: psychobiological and psychosocial effects, Int. Rev. Appl. Psychol., 35, 287, 1986.
412. McCann, B., Warnick, R., and Knopp, R., Changes in plasma lipids and dietary intake accompanying shifts in perceived workload and stress, Psychosom. Med., 52, 97, 1990.
413. Naliboff, B., Benton, D., Solomon, G., Morley, J., Fahey, J., Bloom, E., Makinodan, T., and Gilmore, S., Immunological changes in young and old adults during brief laboratory stress, Psychosom. Med., 53, 121, 1991.
414. Cohen, S., Tyrrell, D. A. J., and Smith, A. P., Psychological stress and susceptibility to the common cold, N. Engl. J. Med., 325, 606, 1991.
415. Hedge, A., New carpet emissions and indoor air quality, in Indoor Environment '93 Conf. Proc., IAQ Publications, Inc., Bethesda, MD, 1993, 206.
416. Dantzer, R., The Psychosomatic Delusion, The Free Press, New York, 1989.